Barriers and strategies to achieve a cure for HIV

被引:94
|
作者
Pitman, Matthew C. [1 ,2 ]
Lau, Jillian S. Y. [3 ]
McMahon, James H. [3 ,4 ]
Lewin, Sharon R. [1 ,2 ,3 ]
机构
[1] Univ Melbourne, Peter Doherty Inst Infect & Immun, Melbourne, Vic 3000, Australia
[2] Royal Melbourne Hosp, Melbourne, Vic, Australia
[3] Monash Univ, Alfred Hosp, Dept Infect Dis, Melbourne, Vic, Australia
[4] Monash Med Ctr, Dept Infect Dis, Clayton, Vic, Australia
来源
LANCET HIV | 2018年 / 5卷 / 06期
基金
澳大利亚国家健康与医学研究理事会; 美国国家卫生研究院; 英国医学研究理事会;
关键词
CD4(+) T-CELLS; SUPPRESSIVE ANTIRETROVIRAL THERAPY; BROADLY NEUTRALIZING ANTIBODIES; TREATMENT INTERRUPTION; IN-VIVO; BISPECIFIC ANTIBODIES; POSTTREATMENT CONTROL; HIV-1-INFECTED CELLS; INFECTED INDIVIDUALS; VIRAL RESERVOIR;
D O I
10.1016/S2352-3018(18)30039-0
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
9 years since the report of a cure for HIV after C-C chemokine receptor type 5.32 stem cell transplantation, no other case of HIV cure has been reported, despite much research. However, substantial progress has been made in understanding the biology of the latent HIV reservoir, and in measuring the amount of virus that persists after antiretroviral therapy (ART) with increasingly sophisticated approaches. This knowledge is being translated into a long pipeline of clinical trials seeking to reduce viral persistence in participants on suppressive treatment and ultimately to allow safe cessation of ART. In this Review, we discuss the main barriers preventing the development of an HIV cure, methods used to measure HIV persistence in individuals on ART, clinical strategies that aim to cure HIV, and future directions for studies in the field of HIV cure research.
引用
收藏
页码:E317 / E328
页数:12
相关论文
共 50 条
  • [21] Developing Combined HIV Vaccine Strategies for a Functional Cure
    Noto, Alessandra
    Trautmann, Lydie
    VACCINES, 2013, 1 (04):
  • [22] Measuring the Success of HIV-1 Cure Strategies
    Thomas, Jordan
    Ruggiero, Alessandra
    Paxton, William A.
    Pollakis, Georgios
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2020, 10
  • [23] HIV-1 cure strategies: why CRISPR?
    Atkins, Andrew J.
    Allen, Alexander G.
    Dampier, Will
    Haddad, Elias K.
    Nonnemacher, Michael R.
    Wigdahl, Brian
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (06) : 781 - 793
  • [24] Block-And-Lock Strategies to Cure HIV Infection
    Vansant, Gerlinde
    Bruggemans, Anne
    Janssens, Julie
    Debyser, Zeger
    VIRUSES-BASEL, 2020, 12 (01):
  • [25] γδ T cells: an immunotherapeutic approach for HIV cure strategies
    Garrido, Carolina
    Clohosey, Matthew L.
    Whitworth, Chloe P.
    Hudgens, Michael
    Margolis, David M.
    Soriano-Sarabia, Natalia
    JCI INSIGHT, 2018, 3 (12)
  • [26] HIV cure strategies: which ones are appropriate for Africa?
    Abana, Christopher Zaab-Yen
    Lamptey, Helena
    Bonney, Evelyn Y.
    Kyei, George B.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2022, 79 (08)
  • [27] Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs
    Katlama, Christine
    Deeks, Steven G.
    Autran, Brigitte
    Martinez-Picado, Javier
    van Lunzen, Jan
    Rouzioux, Christine
    Miller, Michael
    Vella, Stefano
    Schmitz, Joern E.
    Ahlers, Jeffrey
    Richman, Douglas D.
    Sekaly, Rafick P.
    LANCET, 2013, 381 (9883): : 2109 - 2117
  • [28] Editing out HIV: application of gene editing technology to achieve functional cure
    Jingna Xun
    Xinyu Zhang
    Shuyan Guo
    Hongzhou Lu
    Jun Chen
    Retrovirology, 18
  • [29] Scientists Investigate Routing Latent HIV From Its Reservoirs to Achieve a Cure
    Friedrich, M. J.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 308 (04): : 325 - 327
  • [30] Pediatric HIV: the Potential of Immune Therapeutics to Achieve Viral Remission and Functional Cure
    Stella J. Berendam
    Ashley N. Nelson
    Ria Goswami
    Deborah Persaud
    Nancy L. Haigwood
    Ann Chahroudi
    Genevieve G. Fouda
    Sallie R. Permar
    Current HIV/AIDS Reports, 2020, 17 : 237 - 248